Investing Profile

Joachim Rothe

VCInvestor
Partner at EQT Life Sciences
Photo of Joachim Rothe, Partner at EQT Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$11.0M - $65.0M
$25.0M
16
€260M
CompanyStageDateRound SizeTotal Raised
Binx Health
Series FApr 2024$65M
Series EMay 2021$100M
Series DJan 2017$35M
Series BApr 2014$28M
Series BJul 2011$27M
$280M
Co-investors: Matthew Rizzo (OrbiMed), Florent Gros (Earlybird Venture Capital)
DNA Script
Series COct 2021$170M
Series BJul 2020$50M
Series BMay 2019$39M
$470M
Co-investors: Nick Naclerio (Illumina Ventures), Joško Bobanović (Soffinova Partners), Philippe Peltier (Kurma Partners), George C. Petrocheilos (Catalio Capital)
Innovative Molecules
Series AJun 2021$24M
$24M
Nouscom
Series BNov 2017$49M
$140M
Co-investors: Scott Rocklage (5am Ventures), Hakan Goker (M Ventures (Merck)), Sofia Ioannidou (Andera Partners), Guido Magni (Versant Ventures), Genghis Lloyd-Harris (Abingworth)
Luxendo
Series AJan 2017$8M
Series AOct 2015$7M
$15M
Cellerix
Series CJan 2010$38M
Series BNov 2009$40M
Series BSep 2007$37M
$120M
Co-investors: Joël Jean-Mairet (Ysios Capital)
U3 Pharma
Series UnknownMay 2006$34M
$34M